127 related articles for article (PubMed ID: 38264752)
1. Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.
Wang W; Huang G; Lin H; Ren L; Fu L; Mao X
Front Oncol; 2023; 13():1216134. PubMed ID: 38264752
[TBL] [Abstract][Full Text] [Related]
2. Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.
Wang W; Huang G; Lin H; Ren L; Fu L; Mao X
Front Oncol; 2022; 12():1102392. PubMed ID: 36727059
[TBL] [Abstract][Full Text] [Related]
3. Chloride Intracellular Channel Protein 1 (CLIC1) Ιs Over-expressed in Muscle Invasive Urinary Bladder Cancer.
Adelmann TG; Camerota TC; Ceausu AR; Cimpean AM; Mazzanti M; Raica M
Anticancer Res; 2020 Dec; 40(12):6879-6884. PubMed ID: 33288580
[TBL] [Abstract][Full Text] [Related]
4. Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement.
Karaaslan Z; Şengül-Yediel B; Yüceer-Korkmaz H; Şanlı E; Gezen-Ak D; Dursun E; Timirci-Kahraman Ö; Baykal AT; Yılmaz V; Türkoğlu R; Kürtüncü M; Gündüz T; Gürsoy-Özdemir Y; Tüzün E; İsmail Küçükali C
Mult Scler Relat Disord; 2023 Oct; 78():104940. PubMed ID: 37603930
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
Chen K; Zhu S; Yu W; Xia Y; Xing J; Geng J; Cheng F
Front Oncol; 2022; 12():908832. PubMed ID: 35600386
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of clinical prognosis and CLIC1 immune invasion in lung adenocarcinoma.
Chen Z; Chen W; Huang R; Chen D; Li Z; Qi X; Sun L; Lin L; Zhang Z
Medicine (Baltimore); 2022 Sep; 101(39):e30760. PubMed ID: 36181109
[TBL] [Abstract][Full Text] [Related]
7. Is label-free LC-MS/MS ready for biomarker discovery?
Sandin M; Chawade A; Levander F
Proteomics Clin Appl; 2015 Apr; 9(3-4):289-94. PubMed ID: 25656266
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of chloride intracellular channel protein 1 (CLIC1) ameliorates liver fibrosis phenotype by activating the Ca
Ko M; Jung HY; Lee D; Jeon J; Kim J; Baek S; Lee JY; Kim JY; Kwon HJ
Biomed Pharmacother; 2023 Dec; 168():115776. PubMed ID: 37924785
[TBL] [Abstract][Full Text] [Related]
9. The expression and clinical significance of CLIC1 and HSP27 in lung adenocarcinoma.
Wang W; Xu X; Wang W; Shao W; Li L; Yin W; Xiu L; Mo M; Zhao J; He Q; He J
Tumour Biol; 2011 Dec; 32(6):1199-208. PubMed ID: 21858536
[TBL] [Abstract][Full Text] [Related]
10. Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κB.
Wang W; Li X; Xu Y; Guo W; Yu H; Zhang L; Wang Y; Chen X
Cell Oncol (Dordr); 2021 Jun; 44(3):557-568. PubMed ID: 33469837
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Effect of Carbon Ion Radiation Induce Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis.
Yang Z; Zhang Q; Luo H; Shao L; Liu R; Kong Y; Zhao X; Geng Y; Li C; Wang X
Front Oncol; 2021; 11():783377. PubMed ID: 34712618
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas.
Mehta S; Bhimani N; Gill AJ; Samra JS; Sahni S; Mittal A
Front Oncol; 2021; 11():774861. PubMed ID: 34692555
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1.
Zhang W; Mao S; Shi D; Zhang J; Zhang Z; Guo Y; Wu Y; Wang R; Wang L; Huang Y; Yao X
Front Oncol; 2023; 13():1208728. PubMed ID: 37284200
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Hu X; Bao M; Huang J; Zhou L; Zheng S
Front Oncol; 2020; 10():617539. PubMed ID: 33330112
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
16. Corra: Computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics.
Brusniak MY; Bodenmiller B; Campbell D; Cooke K; Eddes J; Garbutt A; Lau H; Letarte S; Mueller LN; Sharma V; Vitek O; Zhang N; Aebersold R; Watts JD
BMC Bioinformatics; 2008 Dec; 9():542. PubMed ID: 19087345
[TBL] [Abstract][Full Text] [Related]
17. A Knock-Down Cell-Based Study for the Functional Analysis of Chloride Intracellular Channel 1 (CLIC1): Integrated Proteomics and Microarray Study.
Yin SJ; Lee JR; Lee BN; Yang JM; Qian GY; Park YD; Hahn MJ
Protein Pept Lett; 2021; 28(1):84-100. PubMed ID: 32586242
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Predicting Outcomes From Radical Radiotherapy for Non-small Cell Lung Cancer: A Systematic Review of the Existing Literature.
Walls GM; Hanna GG; Qi F; Zhao S; Xia J; Ansari MT; Landau D
Front Oncol; 2019; 9():112. PubMed ID: 30881918
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Fragile Gene
Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
Front Oncol; 2021; 11():735435. PubMed ID: 34513711
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Chen Q; Ouyang D; Anwar M; Xie N; Wang S; Fan P; Qian L; Chen G; Zhou E; Guo L; Gu X; Ding B; Yang X; Liu L; Deng C; Xiao Z; Li J; Wang Y; Zeng S; Hu J; Zhou W; Qiu B; Wang Z; Weng J; Liu M; Li Y; Tang T; Wang J; Zhang H; Dai B; Tang W; Wu T; Xiao M; Li X; Liu H; Li L; Yi W; Ouyang Q
Front Oncol; 2021; 11():661128. PubMed ID: 33747972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
